Cargando…

Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma

BACKGROUND: The diagnosis of check-point inhibitor-related pneumonitis (CIP) relies on radiological and clinical patterns which are not specific and can mimic other conditions (cancer progression, infectious diseases or interstitial pneumonitis). Cell pattern analysis of bronchoalveolar lavage (BAL)...

Descripción completa

Detalles Bibliográficos
Autores principales: Strippoli, Sabino, Fucci, Livia, Negri, Antonio, Putignano, Daniela, Cisternino, Marco Luigi, Napoli, Gaetano, Filannino, Ruggiero, De Risi, Ivana, Sciacovelli, Angela Monica, Guida, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727780/
https://www.ncbi.nlm.nih.gov/pubmed/33302981
http://dx.doi.org/10.1186/s12967-020-02650-z
_version_ 1783621127901282304
author Strippoli, Sabino
Fucci, Livia
Negri, Antonio
Putignano, Daniela
Cisternino, Marco Luigi
Napoli, Gaetano
Filannino, Ruggiero
De Risi, Ivana
Sciacovelli, Angela Monica
Guida, Michele
author_facet Strippoli, Sabino
Fucci, Livia
Negri, Antonio
Putignano, Daniela
Cisternino, Marco Luigi
Napoli, Gaetano
Filannino, Ruggiero
De Risi, Ivana
Sciacovelli, Angela Monica
Guida, Michele
author_sort Strippoli, Sabino
collection PubMed
description BACKGROUND: The diagnosis of check-point inhibitor-related pneumonitis (CIP) relies on radiological and clinical patterns which are not specific and can mimic other conditions (cancer progression, infectious diseases or interstitial pneumonitis). Cell pattern analysis of bronchoalveolar lavage (BAL) is well-known to support the diagnosis of interstitial lung disease; nevertheless, this analysis is somewhat performed and not required by immune-toxicity management guidelines for CIP. METHODS: We performed BAL analysis in 5 metastatic melanoma (MM) patients who developed CIP among 112 patients treated with checkpoint inhibitors. We also correlated the BAL features with the computed tomography (CT) scan patterns and with various peripheral blood parameters to better define the profile of this patient population. RESULTS: BAL flow cytometer and cytopathology analyses showed typical and homogeneous features with increased lymphoid population, prevalent CD8 + T cells and inversion of the CD4/CD8 ratio. Moreover, the extent of activated CD3 + HLA-DR + T cells was related to the grading of adverse events. Blood leucocytosis, hypoxemia, normal values for procalcitonin and lactate dehydrogenase were also found together with a cryptogenic organizing pneumonia-like radiologic pattern. In all our patients, CIP was associated with partial or complete response. CONCLUSIONS: Identification of a specific BAL cellular pattern allows clinicians to place this investigation in the appropriate position of CIP diagnosis and management to avoid misdiagnosis or considering this condition as progressive disease and delaying proper treatment.
format Online
Article
Text
id pubmed-7727780
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77277802020-12-10 Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma Strippoli, Sabino Fucci, Livia Negri, Antonio Putignano, Daniela Cisternino, Marco Luigi Napoli, Gaetano Filannino, Ruggiero De Risi, Ivana Sciacovelli, Angela Monica Guida, Michele J Transl Med Research BACKGROUND: The diagnosis of check-point inhibitor-related pneumonitis (CIP) relies on radiological and clinical patterns which are not specific and can mimic other conditions (cancer progression, infectious diseases or interstitial pneumonitis). Cell pattern analysis of bronchoalveolar lavage (BAL) is well-known to support the diagnosis of interstitial lung disease; nevertheless, this analysis is somewhat performed and not required by immune-toxicity management guidelines for CIP. METHODS: We performed BAL analysis in 5 metastatic melanoma (MM) patients who developed CIP among 112 patients treated with checkpoint inhibitors. We also correlated the BAL features with the computed tomography (CT) scan patterns and with various peripheral blood parameters to better define the profile of this patient population. RESULTS: BAL flow cytometer and cytopathology analyses showed typical and homogeneous features with increased lymphoid population, prevalent CD8 + T cells and inversion of the CD4/CD8 ratio. Moreover, the extent of activated CD3 + HLA-DR + T cells was related to the grading of adverse events. Blood leucocytosis, hypoxemia, normal values for procalcitonin and lactate dehydrogenase were also found together with a cryptogenic organizing pneumonia-like radiologic pattern. In all our patients, CIP was associated with partial or complete response. CONCLUSIONS: Identification of a specific BAL cellular pattern allows clinicians to place this investigation in the appropriate position of CIP diagnosis and management to avoid misdiagnosis or considering this condition as progressive disease and delaying proper treatment. BioMed Central 2020-12-10 /pmc/articles/PMC7727780/ /pubmed/33302981 http://dx.doi.org/10.1186/s12967-020-02650-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Strippoli, Sabino
Fucci, Livia
Negri, Antonio
Putignano, Daniela
Cisternino, Marco Luigi
Napoli, Gaetano
Filannino, Ruggiero
De Risi, Ivana
Sciacovelli, Angela Monica
Guida, Michele
Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma
title Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma
title_full Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma
title_fullStr Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma
title_full_unstemmed Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma
title_short Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma
title_sort cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727780/
https://www.ncbi.nlm.nih.gov/pubmed/33302981
http://dx.doi.org/10.1186/s12967-020-02650-z
work_keys_str_mv AT strippolisabino cellularanalysisofbronchoalveolarlavagefluidtonarrowdifferentialdiagnosisofcheckpointinhibitorrelatedpneumonitisinmetastaticmelanoma
AT fuccilivia cellularanalysisofbronchoalveolarlavagefluidtonarrowdifferentialdiagnosisofcheckpointinhibitorrelatedpneumonitisinmetastaticmelanoma
AT negriantonio cellularanalysisofbronchoalveolarlavagefluidtonarrowdifferentialdiagnosisofcheckpointinhibitorrelatedpneumonitisinmetastaticmelanoma
AT putignanodaniela cellularanalysisofbronchoalveolarlavagefluidtonarrowdifferentialdiagnosisofcheckpointinhibitorrelatedpneumonitisinmetastaticmelanoma
AT cisterninomarcoluigi cellularanalysisofbronchoalveolarlavagefluidtonarrowdifferentialdiagnosisofcheckpointinhibitorrelatedpneumonitisinmetastaticmelanoma
AT napoligaetano cellularanalysisofbronchoalveolarlavagefluidtonarrowdifferentialdiagnosisofcheckpointinhibitorrelatedpneumonitisinmetastaticmelanoma
AT filanninoruggiero cellularanalysisofbronchoalveolarlavagefluidtonarrowdifferentialdiagnosisofcheckpointinhibitorrelatedpneumonitisinmetastaticmelanoma
AT derisiivana cellularanalysisofbronchoalveolarlavagefluidtonarrowdifferentialdiagnosisofcheckpointinhibitorrelatedpneumonitisinmetastaticmelanoma
AT sciacovelliangelamonica cellularanalysisofbronchoalveolarlavagefluidtonarrowdifferentialdiagnosisofcheckpointinhibitorrelatedpneumonitisinmetastaticmelanoma
AT guidamichele cellularanalysisofbronchoalveolarlavagefluidtonarrowdifferentialdiagnosisofcheckpointinhibitorrelatedpneumonitisinmetastaticmelanoma